Brief: Therapeuticsmd Announces Submission Of Low Dose Bijuva® 0.5 Mg/100 Mg Supplemental New Drug Application To FDA

TherapeuticsMD

25/05/2021 12:14

May 25 (Reuters) - TherapeuticsMD Inc  TXMD.O :
    * THERAPEUTICSMD ANNOUNCES SUBMISSION OF LOW DOSE BIJUVA®
0.5
MG/100 MG SUPPLEMENTAL NEW DRUG APPLICATION TO FDA
    * THERAPEUTICSMD - EXPECTS TO LEARN OF ACCEPTANCE OF SNDA
UPON
RECEIPT OF FILING REVIEW NOTIFICATION FROM FDA, APPROXIMATELY 74
DAYS AFTER SUBMISSION
    * THERAPEUTICSMD INC - EXPECTS REVIEW TIME UNDER PDUFA WILL
BE
WITHIN TEN MONTHS OF RECEIPT BY FDA, APPROXIMATELY MARCH 21,
2022

Source text for Eikon:  ID:nBw4LqZq7a 
Further company coverage:  TXMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))